Is Pfizer's 6% Dividend Yield Safe? Here's What Investors Need to Know.

Pfizer's vaccine business cooled off, and it is on its back foot in the GLP-1 race, but don't count the drug giant out.

Should You Buy, Sell, or Hold Pfizer at $27?

The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question ...

Is Pfizer (PFE) One of the Best Fortune 500 Dividend Stocks to Invest in Right Now?

With an annual dividend yield of 6.37%, Pfizer Inc. (NYSE:PFE) is included among the 10 Best Fortune 500 Dividend Stocks to ...

Pfizer’s ASCO Oncology Data Puts Future Cancer Revenue Story In Focus

Pfizer (NYSE:PFE) is preparing multiple presentations for the upcoming ASCO conference that spotlight new data across its ...

Pfizer Inc. (PFE): One of the Best Safe Stocks to Invest in for Beginners

We just covered the 15 Safe Stocks to Invest In For Beginners and Pfizer Inc. (NYSE:PFE) ranks 14th on this list. Pfizer Inc.
StockStory.org on MSN

Q4 earnings highs and lows: Pfizer (NYSE:PFE) vs the rest of the branded pharmaceuticals stocks

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers.
Las Vegas Sun

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in ...

Pfizer’s Monthly GLP-1 Push Tests Balance Between Obesity Growth And Dividends

Pfizer (NYSE:PFE) reported Phase 2b results for its GLP-1 anti-obesity candidate, PF-08653944, showing potential for a once ...
The Pharma Letter

Pfizer settles with 3 generics firms over Vyndamax

US pharma giant Pfizer yesterday announced that it has entered into settlement agreements with generic drug manufacturers - ...